top of page

NDRA Registration Waiver Process

  • hivtoolkit
  • Aug 26, 2017
  • 1 min read

National drug regulatory authorities (NDRAs) are mandated to ensure that all medicines and medical devices used in country are safe, effective, and of high quality. It is important to ensure that the drug is registered in-country through an NDRA. It may be possible to obtain an import waiver to enable importation of stringent regulatory authority approved products prior to NDRA review and approval to avoid delays in patient access to new products. This document outlines an illustrative process and requirements for national programs to request a waiver to make products accessible while national registration is underway.



Comments


  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • YouTube

383 Dorchester Avenue, Suite 400

Boston, MA 02127

The goal of the HIV New Product Introduction Toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at HIVToolkit@clintonhealthaccess.org.

 

© 2022  Clinton Health Access Initiative - Global HIV Access Program

bottom of page